Cargando…

MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma

Osteosarcoma is the most prevalent primary bone malignancy in children and young adults. Resistance to chemotherapy remains a key challenge for effective treatment of patients with osteosarcoma. The aim of the present study was to investigate the preventive role of metallothionein-2A (MT2A) in respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mangelinck, Adèle, da Costa, Maria Eugénia Marques, Stefanovska, Bojana, Bawa, Olivia, Polrot, Mélanie, Gaspar, Nathalie, Fromigué, Olivia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707240/ https://www.ncbi.nlm.nih.gov/pubmed/31444479 http://dx.doi.org/10.1038/s41598-019-48846-2

Ejemplares similares

Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma
por: Mangelinck, Adèle, et al.
Publicado: (2021)

Recent advances in understanding osteosarcoma and emerging therapies
por: Gaspar, Nathalie, et al.
Publicado: (2020)

Tribbles Pseudokinase 3 Regulation and Contribution to Cancer
por: Stefanovska, Bojana, et al.
Publicado: (2021)

CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process
por: Habel, Nadia, et al.
Publicado: (2019)

In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice
por: Marques da Costa, Maria Eugénia, et al.
Publicado: (2019)

Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice
por: Marques da Costa, Maria Eugenia, et al.
Publicado: (2018)

Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis
por: Moquin-Beaudry, Gaël, et al.
Publicado: (2023)

FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo
por: Brun, Julia, et al.
Publicado: (2013)

Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance
por: Habel, N, et al.
Publicado: (2013)

MicroRNAs as Biomarkers in Canine Osteosarcoma: A New Future?
por: Gourbault, Olivia, et al.
Publicado: (2020)

Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation
por: Hamidouche, Zahia, et al.
Publicado: (2010)

Chemotherapy for osteosarcoma.
por: Souhami, R. L.
Publicado: (1989)

sCLU as prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Jinfeng, et al.
Publicado: (2019)

Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models
por: da Costa, Maria Eugenia Marques, et al.
Publicado: (2023)

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
por: Feng, Wenlong, et al.
Publicado: (2020)

Role of MicroRNAs in Human Osteosarcoma: Future Perspectives
por: Llobat, Lola, et al.
Publicado: (2021)

Osteosarcoma in Children: Not Only Chemotherapy
por: Argenziano, Maura, et al.
Publicado: (2021)

Intensity of perioperative analgesia but not pre‐treatment pain is predictive of survival in dogs undergoing amputation plus chemotherapy for extremity osteosarcoma
por: Nolan, Michael W., et al.
Publicado: (2022)

Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
por: Hattinger, Claudia Maria, et al.
Publicado: (2021)

MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib
por: Yip, Cassandre, et al.
Publicado: (2017)

Editorial: Cognitive Impairment and Peripheral Neuropathy From Chemotherapy: Molecular Mechanisms and Therapeutic Approaches
por: Milutinovic, Bojana, et al.
Publicado: (2022)

Enrichment of osteosarcoma stem cells by chemotherapy
por: Tang, Qing-Lian, et al.
Publicado: (2011)

Research Progress of Nanomaterials in Chemotherapy of Osteosarcoma
por: Yu, Tianci, et al.
Publicado: (2023)

Melatonin MT(1) and MT(2) Receptors in the Ram Reproductive Tract
por: González-Arto, Marta, et al.
Publicado: (2017)

Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis
por: Ingvarsen, Signe Z., et al.
Publicado: (2020)

miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma
por: Kubota, Daisuke, et al.
Publicado: (2016)

Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma
por: Yong, Bicheng, et al.
Publicado: (2012)

An overview of resistance to chemotherapy in osteosarcoma and future perspectives
por: Garcia-Ortega, Dorian Yarih, et al.
Publicado: (2022)

Nanosized drug delivery strategies in osteosarcoma chemotherapy
por: Chen, Chenglong, et al.
Publicado: (2023)

Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma
por: Gong, Yubao, et al.
Publicado: (2021)

Osteosarcoma mechanobiology and therapeutic targets
por: Shoaib, Zunaira, et al.
Publicado: (2021)

Therapeutic effect of neoadjuvant chemotherapy combined with curettage to treat distal femoral osteosarcoma: A case report
por: Lai, Qi, et al.
Publicado: (2017)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
por: Yu, Lei, et al.
Publicado: (2022)

Peak Plasma Levels of mtDNA Serve as a Predictive Biomarker for COVID-19 in-Hospital Mortality
por: Edinger, Fabian, et al.
Publicado: (2022)

T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Thanindratarn, Pichaya, et al.
Publicado: (2021)

Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2021)

Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
por: Suehara, Yoshiyuki, et al.
Publicado: (2012)

Identification of Prognostic and Predictive Osteosarcoma Biomarkers
por: Zamborsky, Radoslav, et al.
Publicado: (2019)

Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
por: Evola, Francesco R., et al.
Publicado: (2017)

P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma.
por: Shnyder, S. D., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_9lhbrl5s92esobabp8rh3gojmt